Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001171843-17-007436
Filing Date
2017-12-04
Accepted
2017-12-04 16:37:05
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM S-3/A fs3a_120417.htm S-3/A 31126
2 EXHIBIT 5.1 exh_51.htm EX-5.1 35174
3 GRAPHIC image_002.gif GRAPHIC 1816
4 GRAPHIC image_003.gif GRAPHIC 1805
5 GRAPHIC image_004.gif GRAPHIC 2992
6 GRAPHIC image_005.gif GRAPHIC 1772
  Complete submission text file 0001171843-17-007436.txt   78852
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-221421 | Film No.: 171237499
SIC: 2836 Biological Products, (No Diagnostic Substances)